Logo image of CLARI.PA

CLARIANE SE (CLARI.PA) Stock Fundamental Analysis

EPA:CLARI - FR0010386334 - Common Stock

4.142 EUR
-0.14 (-3.22%)
Last: 9/1/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, CLARI scores 3 out of 10 in our fundamental rating. CLARI was compared to 28 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CLARI has reported negative net income.
In the past year CLARI had a positive cash flow from operations.
In multiple years CLARI reported negative net income over the last 5 years.
In the past 5 years CLARI always reported a positive cash flow from operatings.
CLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFCLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

The Return On Assets of CLARI (-0.43%) is worse than 82.14% of its industry peers.
Looking at the Return On Equity, with a value of -1.71%, CLARI is doing worse than 78.57% of the companies in the same industry.
With a Return On Invested Capital value of 1.63%, CLARI is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for CLARI is below the industry average of 6.48%.
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROIC 1.63%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
CLARI.PA Yearly ROA, ROE, ROICCLARI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

The Operating Margin of CLARI (4.80%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLARI has declined.
Looking at the Gross Margin, with a value of 91.90%, CLARI belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
Industry RankSector Rank
OM 4.8%
PM (TTM) N/A
GM 91.9%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
CLARI.PA Yearly Profit, Operating, Gross MarginsCLARI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLARI is destroying value.
The number of shares outstanding for CLARI has been increased compared to 1 year ago.
CLARI has more shares outstanding than it did 5 years ago.
CLARI has a better debt/assets ratio than last year.
CLARI.PA Yearly Shares OutstandingCLARI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CLARI.PA Yearly Total Debt VS Total AssetsCLARI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.63, we must say that CLARI is in the distress zone and has some risk of bankruptcy.
CLARI's Altman-Z score of 0.63 is on the low side compared to the rest of the industry. CLARI is outperformed by 71.43% of its industry peers.
CLARI has a debt to FCF ratio of 13.25. This is a negative value and a sign of low solvency as CLARI would need 13.25 years to pay back of all of its debts.
With a Debt to FCF ratio value of 13.25, CLARI is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
CLARI has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
CLARI has a worse Debt to Equity ratio (1.90) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Altman-Z 0.63
ROIC/WACC0.45
WACC3.63%
CLARI.PA Yearly LT Debt VS Equity VS FCFCLARI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.67 indicates that CLARI may have some problems paying its short term obligations.
With a Current ratio value of 0.67, CLARI is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.65 indicates that CLARI may have some problems paying its short term obligations.
CLARI has a worse Quick ratio (0.65) than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.65
CLARI.PA Yearly Current Assets VS Current LiabilitesCLARI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.49%, which is quite impressive.
Looking at the last year, CLARI shows a small growth in Revenue. The Revenue has grown by 2.70% in the last year.
The Revenue has been growing slightly by 7.89% on average over the past years.
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%

3.2 Future

The Earnings Per Share is expected to grow by 39.62% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.11% on average over the next years.
EPS Next Y163.95%
EPS Next 2Y86.53%
EPS Next 3Y58.55%
EPS Next 5Y39.62%
Revenue Next Year2.24%
Revenue Next 2Y3.3%
Revenue Next 3Y3.65%
Revenue Next 5Y4.11%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLARI.PA Yearly Revenue VS EstimatesCLARI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
CLARI.PA Yearly EPS VS EstimatesCLARI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CLARI is valuated reasonably with a Price/Forward Earnings ratio of 11.44.
Based on the Price/Forward Earnings ratio, CLARI is valued a bit cheaper than 75.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CLARI to the average of the S&P500 Index (22.76), we can say CLARI is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.44
CLARI.PA Price Earnings VS Forward Price EarningsCLARI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

67.86% of the companies in the same industry are more expensive than CLARI, based on the Enterprise Value to EBITDA ratio.
CLARI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CLARI is cheaper than 96.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.39
EV/EBITDA 8.59
CLARI.PA Per share dataCLARI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLARI's earnings are expected to grow with 58.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.53%
EPS Next 3Y58.55%

More info and screens

5

5. Dividend

5.1 Amount

CLARI has a Yearly Dividend Yield of 10.64%, which is a nice return.
Compared to an average industry Dividend Yield of 2.70, CLARI pays a better dividend. On top of this CLARI pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CLARI pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.64%

5.2 History

The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
CLARI.PA Yearly Dividends per shareCLARI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

CLARI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-110.43%
EPS Next 2Y86.53%
EPS Next 3Y58.55%
CLARI.PA Yearly Income VS Free CF VS DividendCLARI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

More info and screens

CLARIANE SE

EPA:CLARI (9/1/2025, 7:00:00 PM)

4.142

-0.14 (-3.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-29 2025-07-29
Earnings (Next)10-27 2025-10-27
Inst Owners42.42%
Inst Owner ChangeN/A
Ins Owners5.64%
Ins Owner ChangeN/A
Market Cap1.48B
Analysts77.14
Price Target4.79 (15.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.64%
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-110.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.45%
PT rev (3m)71.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)11.76%
EPS NY rev (3m)11.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.44
P/S 0.28
P/FCF 2.39
P/OCF 1.67
P/B 0.41
P/tB N/A
EV/EBITDA 8.59
EPS(TTM)-0.17
EYN/A
EPS(NY)0.36
Fwd EY8.75%
FCF(TTM)1.73
FCFY41.82%
OCF(TTM)2.47
OCFY59.74%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROCE 2.21%
ROIC 1.63%
ROICexc 1.74%
ROICexgc 3.53%
OM 4.8%
PM (TTM) N/A
GM 91.9%
FCFM 11.64%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Debt/EBITDA 6.54
Cap/Depr 33.63%
Cap/Sales 4.99%
Interest Coverage 0.83
Cash Conversion 84.71%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.65
Altman-Z 0.63
F-Score6
WACC3.63%
ROIC/WACC0.45
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y163.95%
EPS Next 2Y86.53%
EPS Next 3Y58.55%
EPS Next 5Y39.62%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year2.24%
Revenue Next 2Y3.3%
Revenue Next 3Y3.65%
Revenue Next 5Y4.11%
EBIT growth 1Y-22.25%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year308.46%
EBIT Next 3Y69.88%
EBIT Next 5Y38.4%
FCF growth 1Y267.6%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%